Nicole A. Doudican, Ph.D.
Affiliations: | 2004 | Emory University, Atlanta, GA |
Area:
Genetics, Molecular BiologyGoogle:
"Nicole Doudican"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Paul W. Doetsch | grad student | 2004 | Emory | |
| (Determinants of mitochondrial genomic stability in Saccharomyces cerevisiae.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Browning JR, Derr P, Derr K, et al. (2020) A 3D biofabricated cutaneous squamous cell carcinoma tissue model with multi-channel confocal microscopy imaging biomarkers to quantify antitumor effects of chemotherapeutics in tissue. Oncotarget. 11: 2587-2596 |
| Babadzhanov M, Doudican N, Wilken R, et al. (2020) Current concepts and approaches to merkel cell carcinoma. Archives of Dermatological Research |
| Canavan TN, Doudican NA, Stevenson M, et al. (2019) Real-world Merkel cell carcinoma outcomes from a tertiary care center. Journal of Clinical Oncology. 37: e14098-e14098 |
| Abikhair Burgo M, Roudiani N, Chen J, et al. (2018) Ruxolitinib inhibits cyclosporine-induced proliferation of cutaneous squamous cell carcinoma. Jci Insight. 3 |
| Doudican NA, Orlow SJ. (2016) Inhibition of the CRAF/prohibitin interaction reverses CRAF-dependent resistance to vemurafenib Oncogene |
| Doudican NA, Kumar A, Singh NK, et al. (2015) Personalization of cancer treatment using predictive simulation. Journal of Translational Medicine. 13: 43 |
| Bhagavathi N, Talia B, Doudican NA, et al. (2015) Netrin-1 Promotes Osteoclast Activity in Multiple Myeloma Under Hypoxic Conditions: Modulation By a RANKL Inhibitor Blood. 126: 1781-1781 |
| Doudican NA, Mazumder A, Vali S, et al. (2015) Abstract 5443: Predictive simulation-driven personalization methodology for refractory multiple myeloma Cancer Research. 75: 5443-5443 |
| Doudican NA, Mazumder A, Kapoor S, et al. (2014) Predictive simulation approach for designing cancer therapeutic regimens with novel biological mechanisms. Journal of Cancer. 5: 406-16 |
| Doudican NA, Wen SY, Mazumder A, et al. (2014) Identification of agents that promote endoplasmic reticulum stress using an assay that monitors luciferase secretion. Journal of Biomolecular Screening. 19: 575-84 |